Cortical lesions are a crucial part of MS pathology and it is critical to determine that new MS therapies have the ability to alter cortical inflammatory lesions given the differences between white and gray matter lesions. We tested lipoic acid (LA) in a mouse focal cortical EAE model. Brain sections were stained with antibodies against CD4, CD11b and galectin-3. Compared with vehicle, treatment with LA significantly decreased CD4 + and galectin-3+ immune cells in the brain. LA treated mice had fewer galectin-3+ cells with no projections indicating decrease in the number of infiltrating monocytes. LA significantly reduces inflammation in a focal cortical model of MS.
Introduction
Multiple sclerosis (MS) is a debilitating disease that causes inflammation, demyelination, neuronal injury and axonal loss in the central nervous system. MS has traditionally been thought to be a disease associated with white matter, but recent studies have shown substantial cerebral cortex lesions and gray matter pathology (Vercellino et al., 2005) . The histopathological characteristics of gray matter lesions differ from the lesions located in the white matter. Experimental autoimmune encephalomyelitis (EAE) is an important animal model that has been successfully used to study and develop various therapies for MS. There have been many different ways of inducing MS like disease in mice but none of the existing mice models are suitable to understand the heterogeneity of cortical lesions in the brain. Focal lesion models can be used to monitor specific lesions and treatment effects. Various focal EAE models have been developed in rats by injecting cytokines (Kerschensteiner et al., 2004; Merkler et al., 2006) and vascular endothelial growth factor (Sasaki et al., 2010) in spinal cord or brain.
Airas et al., 2015 used stereotactic injection of heat-killed Bacillus Calmette-Guerin (BCG) and activation using intradermal injection of BCG in complete Freund adjuvant. In this paper we assessed a focal cortical lesion model in mouse by injecting proinflammatory cytokines in mice immunized with myelin oligodendrocyte glycoprotein (MOG). We used this focal model to study the effects of lipoic acid on brain cortical lesion.
Lipoic acid is a natural antioxidant. It suppresses and treats EAE and EAON (Chaudhary et al., 2011; Chaudhary et al., 2006; Marracci et al., 2002; Morini et al., 2004; Schreibelt et al., 2006) . LA mediates its effect by inhibiting T cell migration into the CNS, decreasing endothelial cell adhesion molecule expression and reduction in MMP-9 production. The objective of this study was to determine the effects of LA on inflammatory cells in a focal cortical EAE model of MS.
Material and methods

EAE induction and disease scores
EAE was induced in C57BL/6 (The Jackson Laboratory, Bar Harbor, ME) female mice (8-10 weeks old). C57BL/6 were immunized with 200 μg of MOG 35-55 peptide (PolyPeptide Laboratories, San Diego, CA) in complete Freund's adjuvant containing 400 μg of Mycobacterium tuberculosis per mouse by subcutaneous (s.c.) injection (a total volume of 0.2 ml). Pertussis toxin (List Biological Labs Inc., Campbell, CA) was
